Rocky Mountain MS Clinic and Research Group Publications and Presentations

› Poster Presentation: A Management Method for Natalizumab Administration

Kara L. Menning FNP-C, MSCN, Molly F. Roy MPAS, PA-C, John F. Foley, MD

In this study, we present a set of protocols for natalizumab administration and management in the setting of an integrated outpatient clinic and infusion suite utilizing GE Centricity electronic medical record keeping and data analysis via SQL data warehousing. 

› Poster Presentation: CD 4 dynamics in a natalizumab population

John F. Foley

An open-label study of patients with relapsing forms of MS designed to assess the biochemical, immunicological, and pharmacokinetic profiles of a large, actively infusing natalizumab patient cohort. 

› Poster Presentation: Natalizumab Discontinuation Predisposes to Serious Infusion Related Reactions and Antibody Formation

John F. Foley, MD

This analysis was undertaken to assess the effect of natalizumab discontinuation and rechallenge on the subsequent occurence of serious infusions reactions and antibody formation. 

› Poster Presentation: Natalizumab Kinetics and Dose Extension: Defining the Therapeutic Envelope Poster Mapping

John F. Foley MD, Angelene Christensen PN, Tammy Anderson MS

271 patients were evaluated in two investigator initiated trials in an effort to define the immunologic, pharmacokinetic, and cell trafficing characteristics of steady state infusing natalizumab population.